E3S Web Conf.
Volume 292, 20212021 2nd International Conference on New Energy Technology and Industrial Development (NETID 2021)
|Number of page(s)||7|
|Section||Environmental Sustainable Development and Industrial Transformation|
|Published online||09 September 2021|
The review of COVID-19 and the current progress in intervention and diagnostics
1 Xinxiang Medical University, China
2 Shanghai Pinghe School, China
3 Changchun University of Science and Technology, School of Life Science and Technology, China
4 Nanjing Jinling Highschool, International Department, China
† These authors contributed equally.
* Corresponding author: Liwei Guo email@example.com
COVID-19 was first reported in Wuhan city of Hubei Province of China in December 2019, becoming a pandemic declared by the world health organization. This article is a review of the novel coronavirus disease (COVID-19). It typically informs the genome structure of the SARS-CoV-2 and its pathogenic mechanisms, concludes a series of non-pharmaceutical control methods, and focuses on several testing measures. The inventions of the disease treatments remain an important challenge to all medical institutions while a series of medications have been brought to the public.
© The Authors, published by EDP Sciences, 2021
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.